589 related articles for article (PubMed ID: 24787633)
1. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN
Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in Grasse Hospital (2005-2008)].
Leotard S; Negrin N
Pathol Biol (Paris); 2010 Feb; 58(1):35-8. PubMed ID: 19864086
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
[TBL] [Abstract][Full Text] [Related]
11. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
12. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Chang UI; Kim HW; Wie SH
Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).
Talan DA; Takhar SS; Krishnadasan A; Abrahamian FM; Mower WR; Moran GJ;
Emerg Infect Dis; 2016 Sep; 22(9):1594-603. PubMed ID: 27532362
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
[TBL] [Abstract][Full Text] [Related]
15. [Acute complicated and uncomplicated pyelonephritis in the emergency department: process-of-care indicators and outcomes].
Delgado Vicente M; Lecaroz Agara MC; Barrios Andrés JL; Canut Blasco A
Emergencias; 2017 Feb; 29(1):27-32. PubMed ID: 28825265
[TBL] [Abstract][Full Text] [Related]
16. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
Wie SH; Kim HW; Chang UI
Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
[TBL] [Abstract][Full Text] [Related]
17. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone.
Lee S; Song DY; Cho SH; Kwon KT
Microb Drug Resist; 2014 Feb; 20(1):39-44. PubMed ID: 23941639
[TBL] [Abstract][Full Text] [Related]
18. [Evolution of third-generation cephalosporin resistance in Enterobacteriaceae from 2000 to 2008 in a Perpignan hospital].
Mayoral G; Ferreyra M; Eden A; Gueudet P; Miquel C; Lecaillon E
Pathol Biol (Paris); 2010 Feb; 58(1):7-10. PubMed ID: 19854588
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
Chang UI; Kim HW; Noh YS; Wie SH
Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
